Poniard Pharmaceuticals, Inc.
PARD · OTC
12/31/2010 | 12/31/2009 | 12/31/2008 | 12/31/2007 | |
|---|---|---|---|---|
| Market Cap | $24,367 | $64,548 | $16,736 | $33,915 |
| - Cash | $1,284 | $15,938 | $44,144 | $29,335 |
| + Debt | $1,574 | $20,270 | $25,395 | $10,808 |
| Enterprise Value | $24,657 | $68,880 | -$2,013 | $15,388 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$25,019 | -$38,967 | -$47,554 | -$29,529 |
| % Margin | – | – | – | – |
| Net Income | -$30,051 | -$45,715 | -$48,565 | -$32,782 |
| % Margin | – | – | – | – |
| EPS Diluted | -26.4 | -52.4 | -56.4 | -43.2 |
| % Growth | 49.6% | 7.1% | -30.6% | – |
| Operating Cash Flow | -$24,276 | -$35,491 | -$33,487 | -$24,653 |
| Capital Expenditures | -$7 | -$21 | -$391 | -$5,773 |
| Free Cash Flow | -$24,283 | -$35,512 | -$33,878 | -$30,426 |